These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Alterations in plasma lecithin:cholesterol acyltransferase and myeloperoxidase in acute myocardial infarction: implications for cardiac outcome. Dullaart RP; Tietge UJ; Kwakernaak AJ; Dikkeschei BD; Perton F; Tio RA Atherosclerosis; 2014 May; 234(1):185-92. PubMed ID: 24661908 [TBL] [Abstract][Full Text] [Related]
28. The long-term prognostic value of multiple biomarkers following a myocardial infarction. Brügger-Andersen T; Aarsetøy H; Grundt H; Staines H; Nilsen DW Thromb Res; 2008; 123(1):60-6. PubMed ID: 18387656 [TBL] [Abstract][Full Text] [Related]
29. Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure. Ng LL; Pathik B; Loke IW; Squire IB; Davies JE Am Heart J; 2006 Jul; 152(1):94-101. PubMed ID: 16824837 [TBL] [Abstract][Full Text] [Related]
30. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure. Skoglund PH; Arpegård J; Ostergren J; Svensson P Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529 [TBL] [Abstract][Full Text] [Related]
31. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome. Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480 [TBL] [Abstract][Full Text] [Related]
36. Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy. Lindahl B; Lindbäck J; Jernberg T; Johnston N; Stridsberg M; Venge P; Wallentin L J Am Coll Cardiol; 2005 Feb; 45(4):533-41. PubMed ID: 15708700 [TBL] [Abstract][Full Text] [Related]
37. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis. Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992 [TBL] [Abstract][Full Text] [Related]
38. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction. Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526 [TBL] [Abstract][Full Text] [Related]
39. Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction. Sarullo FM; Gristina T; Brusca I; Serio G; Taormina A; La Chiusa SM; Castello A; Borruso E; Paterna S; Di Pasquale P Minerva Cardioangiol; 2007 Apr; 55(2):149-55. PubMed ID: 17342035 [TBL] [Abstract][Full Text] [Related]
40. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention. Kwon TG; Bae JH; Jeong MH; Kim YJ; Hur SH; Seong IW; Cho MC; Seung KB; Jang YS; Park SJ; Int J Cardiol; 2009 Apr; 133(2):173-8. PubMed ID: 18281115 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]